Trinity Biotech PLC
TRIB- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000888721
No open-market purchases or sales by Trinity Biotech PLC insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $379.5K in total; no superinvestor holds it.
Holders of 5% or more of TRIB
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Trinity Biotech PLC, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| MiCo IVD Holdings, LLC | 13D/A | 18.00%69.5M shares | – | Dec 19, 20241 filing | Dec 19, 2024 | SEC |
| MiCo IVD Holdings, LLC | 13D/A | 17.00%69.5M shares | 0.00 ppfrom 17.00% | Dec 4, 20252 filings | Dec 10, 2025 | SEC |
| Perceptive Advisors LLC | 13D/A | 9.90%1.50B shares | −12.60 ppfrom 22.50% | Feb 14, 20254 filings | Dec 23, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
9 Schedule 13D and 13G filings on Trinity Biotech PLC, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Dec 23, 20254:49 PM ET | Perceptive Advisors LLCand 4 others | 13D/A | 9.90%1.50B shares | −12.60 ppfrom 22.50% | Dec 22, 2025 | SEC |
| Dec 15, 20259:16 PM ET | DAYLI Partners, Inc.and 2 others | 13D/A | 0.00%0 shares | –Below 5% | Dec 2, 2025 | SEC |
| Dec 10, 20258:51 PM ET | MiCo IVD Holdings, LLCand 2 others | 13D/A | 17.00%69.5M shares | 0.00 ppfrom 17.00% | Dec 8, 2025 | SEC |
| Dec 4, 20258:27 PM ET | MiCo IVD Holdings, LLCand 2 others | 13D/A | 17.00%69.5M shares | – | Dec 2, 2025 | SEC |
| Oct 24, 20257:30 PM ET | Perceptive Advisors LLCand 4 others | 13D/A | 22.50%100.8M shares | +2.70 ppfrom 19.80% | Oct 23, 2025 | SEC |
| Mar 25, 20256:29 PM ET | Perceptive Advisors LLCand 4 others | 13D/A | 19.80%85.8M shares | −1.10 ppfrom 20.90% | Mar 21, 2025 | SEC |
| Feb 14, 20254:15 PM ET | Perceptive Advisors LLCand 4 others | 13D/A | 20.90%85.8M shares | – | Dec 31, 2024 | SEC |
| Dec 26, 20246:19 PM ET | New Main Equity Co., Ltd.and 3 others | 13D | 0.00%0 shares | NewBelow 5% | Dec 20, 2024 | SEC |
| Dec 19, 20249:55 PM ET | MiCo IVD Holdings, LLCand 3 others | 13D/A | 18.00%69.5M shares | – | Dec 17, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Trinity Biotech PLC shares.
No Form 144 notices for Trinity Biotech PLC are on file.